Vitamin E analog, alpha-tocopherol ether-linked acetic acid analog, alone and in combination with celecoxib, reduces multiplicity of ultraviolet-induced skin cancers in mice

Anti-Cancer Drugs

Volumn 19, Issue 2, 2008, Pages 175-181

  Riedel, Shelley B ^a   Fischer, Susan M ^b   Sanders, Bob G ^a   Kline, Kimberly ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Alpha tocopherol ether linked acetic acid analog; Celecoxib; Nonmelanoma skin cancer; SKH 1 hairless mice; Ultraviolet induced skin cancer; Vitamin E analog

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHEROL ETHER LINKED ACETIC ACID; CELECOXIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG FORMULATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CANCER; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; ULTRAVIOLET RADIATION;

ACETIC ACIDS; ADMINISTRATION, INHALATION; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CYCLOOXYGENASE INHIBITORS; LIPOSOMES; MICE; MICE, INBRED HRS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SQUAMOUS CELL; PYRAZOLES; RADIATION DOSAGE; SKIN; SKIN NEOPLASMS; SULFONAMIDES; TIME FACTORS; TOCOPHEROLS; TREATMENT OUTCOME; ULTRAVIOLET RAYS;

EID: 37849009433     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e3282f28ffb     Document Type: Article

References (20)

1. Almahroos M, Kurban AK. Ultraviolet carcinogenesis in nonmelanoma skin cancer. Part I: incidence rates in relation to geographic locations and in migrant populations. Skinmed 2004; 3:29-35; quiz 35-36.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
3. Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley CC, Weaver AL, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005; 294:681-690.
4. De Gruijl FR, van Kranen HJ, Mullenders LH. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B 2001; 63:19-27.
5. Einspahr JG, Stratton SP, Bowden GT, Alberts DS. Chemoprevention of human skin cancer. Crit Rev Oncol Hematol 2002; 41:269-285.
6. Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 1999; 25:231-240.
7. Wilgus TA, Ross MS, Parrett ML, Oberyszyn TM. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins Other Lipid Mediat 2000; 62:367-384.
8. Lupulescu A. Enhancement of carcinogenesis by prostaglandins. Nature 1978; 272:634-636.
9. Wilgus TA, Koki AT, Zweifel BS, Rubal PA, Oberyszyn TM. Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer. Mol Carcinog 2003; 38:33-39.
10. Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol Carcinog 2003; 38:49-58.
11. Fischer SM, Conti CJ, Viner J, Aldaz CM, Lubet RA. Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice. Carcinogenesis 2003; 24: 945-952.
12. Zhang S, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K. Vitamin E analog alpha-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice. Breast Cancer Res Treat 2004; 87:111-121.
13. Shun MC, Yu W, Gapor A, Parsons R, Atkinson J, Sanders BG, et al. Pro-apoptotic mechanisms of action of a novel vitamin E analog (alpha-TEA) and a naturally occurring form of vitamin E (delta-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer 2004; 48:95-105.
14. Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K. Alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells. Apoptosis 2006; 11:1813-1823.
15. Ananthaswamy HN. Sunlight and skin cancer. J Biomed Biotechnol 2001; 1:49.
16. Ouhtit A, Gorny A, Muller HK, Hill LL, Owen-Schaub L, Ananthaswamy HN. Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesis. Am J Pathol 2000; 157:1975-1981.
17. Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L, Knight V, et al. Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol Cancer Ther 2003; 2:437-444.
18. Lawson KA, Anderson K, Snyder RM, Simmons-Menchaca M, Atkinson J, Sun LZ, et al. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis. Cancer Chemother Pharmacol 2004; 54:421-431.
19. Lawson KA, Anderson K, Simmons-Menchaca M, Atkinson J, Sun L, Sanders BG, et al. Comparison of vitamin E derivatives alpha-TEA and VES in reduction of mouse mammary tumor burden and metastasis. Exp Biol Med (Maywood) 2004; 229:954-963.
20. Anderson K, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K. Alpha-TEA plus cisplatin reduces human cisplatin-resistant ovarian cancer cell tumor burden and metastasis. Exp Biol Med (Maywood) 2004; 229:1169-1176.